Company Overview and News

 
Freehold Royalties Ltd. Declares Dividend for October 2018

2018-10-11 globenewswire
CALGARY, Alberta, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on November 15, 2018 to shareholders of record on October 31, 2018.
FRU FRHLF

 
Freehold Royalties Ltd. Declares Dividend for September 2018

2018-09-06 globenewswire
CALGARY, Alberta, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on October 15, 2018 to shareholders of record on September 30, 2018.
FRU FRHLF

 
Freehold Royalties Ltd 2018 Q2 - Results - Earnings Call Slides

2018-08-06 seekingalpha
The following slide deck was published by Freehold Royalties Ltd in conjunction with their 2018 Q2 earnings call.
FRU FRHLF

 
Freehold Royalties Ltd (FRHLF) CEO Thomas Mullane on Q2 2018 Results - Earnings Call Transcript

2018-08-05 seekingalpha
Good morning, ladies and gentlemen. Welcome to the Freehold Royalties Ltd. Second Quarter Conference Call. Please be advised that certain statements on the call constitute forward-looking information. These statements relate to future events, or our expectations for future performance. All statements, other than those of historical facts, may be forward-looking, and we caution the listener.
FRU FRHLF

 
Freehold Royalties Ltd. Strong Growth in Funds from Operations and Second Quarter Results

2018-08-02 globenewswire
CALGARY, Alberta, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced second quarter results for the period ended June 30, 2018.
FRU FRHLF

 
Freehold Royalties Ltd. Declares Dividend for July 2018

2018-07-12 globenewswire
CALGARY, Alberta, July 12, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on August 15, 2018 to shareholders of record on July 31, 2018.
FRU FRHLF

10
This Little Known Oil Stock Has Outperformed The Dividend Aristrocrats

2018-06-29 seekingalpha
Using very little debt Freehold has outperformed most large cap oil stocks even without having downstream operations that some of its large cap brethren have.
FRU BOE XOM DVN FRHLF

 
Freehold Royalties Ltd. Declares Dividend for June 2018

2018-06-12 globenewswire
CALGARY, Alberta, June 12, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on July 16, 2018 to shareholders of record on June 30, 2018.
FRU FRHLF

 
Freehold Royalties' (FRHLF) CEO Tom Mullane on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Please be advised that certain statements on this call constitute forward-looking information. These statements relate to future events or our expectations for future performance. All statements, other than those of historical facts, may be forward-looking and we caution the listener.
FRU FRHLF

 
Freehold Royalties Ltd. Shareholders Approve Resolutions at Annual Meeting

2018-05-10 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced today that all nominees listed in its notice of meeting and information circular dated March 23, 2018, were elected as directors of Freehold at its Annual Meeting of Shareholders held today in Calgary.
FRU FRHLF

 
Freehold Royalties Ltd. Announces Continued Royalty Growth and First Quarter Results

2018-05-09 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced first quarter results for the period ended March 31, 2018.
FRU FRHLF

 
Freehold Royalties Ltd. Declares Dividend for April 2018

2018-04-11 globenewswire
CALGARY, Alberta, April 11, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on May 15, 2018 to shareholders of record on April 30, 2018.
FRU FRHLF

 
Freehold Royalties Ltd. Announces Investor Day Event

2018-04-09 globenewswire
CALGARY, Alberta, April 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces it will hold its Investor Day in Toronto today beginning at 3:00pm EST. The event will include a formal presentation by Freehold's management and technical teams, showcasing Freehold's 2017 Asset Book.
FRU FRHLF

 
Freehold Royalties Ltd 2017 Q4 - Results - Earnings Call Slides

2018-03-12 seekingalpha
The following slide deck was published by Freehold Royalties Ltd in conjunction with their 2017 Q4 earnings call.
FRU FRHLF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 356500108